George Lau

1994–2025 年に発表

120
論文数
28,156
被引用数
80
h 指数
113
i10 指数

被引用数

George Lau の年別被引用数1979 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 4 件1998 年: 被引用 7 件1999 年: 被引用 6 件2000 年: 被引用 8 件2001 年: 被引用 22 件2002 年: 被引用 16 件2003 年: 被引用 39 件2004 年: 被引用 65 件2005 年: 被引用 102 件2006 年: 被引用 131 件2007 年: 被引用 148 件2008 年: 被引用 187 件2009 年: 被引用 201 件2010 年: 被引用 200 件2011 年: 被引用 210 件2012 年: 被引用 202 件2013 年: 被引用 195 件2014 年: 被引用 161 件2015 年: 被引用 164 件2016 年: 被引用 161 件2017 年: 被引用 152 件2018 年: 被引用 153 件2019 年: 被引用 518 件2020 年: 被引用 805 件2021 年: 被引用 807 件2022 年: 被引用 634 件2023 年: 被引用 541 件2024 年: 被引用 917 件2025 年: 被引用 468 件2026 年: 被引用 23 件1980〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 1,747 件、この内訳の 15.9%アメリカ合衆国: 引用元論文 1,639 件、この内訳の 14.9%イギリス: 引用元論文 509 件、この内訳の 4.6%ドイツ: 引用元論文 472 件、この内訳の 4.3%イタリア: 引用元論文 469 件、この内訳の 4.3%日本: 引用元論文 445 件、この内訳の 4.1%台湾: 引用元論文 428 件、この内訳の 3.9%フランス: 引用元論文 394 件、この内訳の 3.6%香港: 引用元論文 380 件、この内訳の 3.5%インド: 引用元論文 369 件、この内訳の 3.4%韓国: 引用元論文 368 件、この内訳の 3.4%スペイン: 引用元論文 319 件、この内訳の 2.9%
0%15.9%その他 31.2%

分野

  • Medicine85.4%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Immunology and Microbiology2.5%
  • Materials Science1.5%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Computer Science0.6%
  • その他2.8%

トピック

  • Hepatitis B Virus Studies12%
  • Hepatitis C virus research10.6%
  • Liver Disease Diagnosis and Treatment10.6%
  • Hepatocellular Carcinoma Treatment and Prognosis4.9%
  • Liver Disease and Transplantation4.2%
  • Hepatitis Viruses Studies and Epidemiology3%
  • その他54.7%

共著者

全論文

検索で開く
  1. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruno Sangro - NEJM Evidence 2022 被引用: 1,432

  2. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Man‐Fung Yuen, Shu Zheng, Jia‐Horng Kao - Hepatology International 2015 被引用: 2,564

  3. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adilson Faccio, Andrea Moretto, Nils Gunnar Skare, Jamille Dutra, Luciana Viola, Karina Vianna, Fernando Meton, Cláudia Vaz de Melo Sette, Amanda Faulhaber, Vincent C. Tam, Félix Couture, Jim Biagi, Hélène Castel, Karen Mulder, Yoo‐Joung Ko, Kevin Zbuk, Stephen Welch, Annie Beaudoin, Alexandra Heurgué, Éric Assenat, Isabelle Archambeaud, David Tougeron, Jean‐Marie Péron, Marine Gilabert, Jean–Pierre Bronowicki, Stéphane Cattan, Jean‐Frédéric Blanc, Mohamed Bouattour, Jean–Marc Phelip, Valérie Boige, Pierre Michel, Anne-Claire Frin, Enrico N. De Toni, Marie‐Luise Berres, Arndt Vogel, Thomas Berg, Thomas J. Ettrich, Dirk Waldschmidt, H. Wedemeyer, Marcus‐Alexander Wörns, Michael Bitzer, Karl-Heinz Weiss, George Lau, Stephen L. Chan, Thomas Yau, Y. Tai, Ann Shing Lee, Satheesh Chiradoni Thungappa, Lokesh K. N, Vikas Sureshchand Ostwal, Kattimani Kiran Ashok, Sushant Mittal, Hari Om Goyal, Sankar Srinivasan, Ghanashyam Biswas, Mallavarapu Mohan, Sewanti Limaye, Nirav Asarawala, Lorenza Rimassa, Alfredo Falcone, Luca Gianni, Antonio Gasbarrini, Bruno Daniele, Antonio Avallone, Giovanni Luca Frassineti, Fausto Roila, Masatoshi Kudo, Tomokazu Kawaoka, Manabu Morimoto, Yasuhiro Takikawa ほか 103 名 - Annals of Oncology 2024 被引用: 312

  4. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal ほか 12 名 - Hepatology International 2019 被引用: 889

  5. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Efrat Broide, Michal Carmiel, Douglas Denham, L. Di Cesare, Dan L. Dumitraşcu, Adi Francis, Samer Gawrieh, María Saraí González Huezo, Patrick Hillon, A De Molina Iracheta, Zeid Kayali, Limas Kupčinskas, George Lau, Lawrence Serfaty, Aline Le Cleach, C. Loguercio, M.P. Manns, Brittany Saldivar, Edward Mena, Luis Alonso Morales-Garza, J NEUTEL, L R Nikoleishvili, Mazen Noureddin, R. Pais, Alfonso Paredes, Marcelo Paredes, Runa Watkins, Antonio Picardi, Mario Pirisi, Gonzalo Pizarro Jofré, Liliana Preoțescu, Tarek Saadi, Didier Samuel, J.F. Sánchez-Ávila, Ingolf Schiefke, Oren Shibolet, M. Shadab Siddiqui, G. Torres-Mendoza, J.F. Trotter, Eugenia Tsai, Elizabeth C. Verna, E. Zuckerman, Dinah Zur, Arun J. Sanyal - Nature Medicine 2021 被引用: 215

  6. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 400

  7. Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice

    著者: , , , , , , , , , , , - Aging 2020 被引用: 206

  8. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2021 被引用: 171

  9. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2005 被引用: 1,521

  10. Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

    著者: , , , , - Journal of Gastroenterology and Hepatology 2007 被引用: 522

  11. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Atsushi Tanaka, Jidong Jia - Hepatology International 2022 被引用: 123

  12. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 被引用: 83

  13. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana A. Payawal, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, George Lau, Fazal Karim, Padaki Nagaraja Rao, Richard Moreau, Pratik Jain, P. Bhatia, G. Kumar, Shiv Kumar Sarin - Hepatology International 2017 被引用: 220

  14. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

    著者: , , , , , , , , , - Gastroenterology 2004 被引用: 899

  15. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teresa LaMasters, Robert G. Gish, Huijie Zhang, Marius Nedelcu, Wah‐Kheong Chan, Mingfeng Xia, Fernando Bril, Junping Shi, Christian Datz, Stefano Romeo, Jian Sun, Dan Liu, Silvia Sookoian, Yimin Mao, Nahum Méndez-Sánchez, Xiaoyan Wang, Nikolaos T. Pyrsopoulos, Jian‐Gao Fan, Yasser Fouad, Dan-Qin Sun, Cosimo Giannini, Jin Chai, Ze-Feng Xia, Dae Won Jun, Guojing Li, Sombat Treeprasertsuk, Ying-Xu Li, Tan To Cheung, Faming Zhang, George Boon‐Bee Goh, Masato Furuhashi, Wai‐Kay Seto, Hui Huang, Anna Di Sessa, Qing-Hong Li, Evangelos Cholongitas, Le Zhang, Themis Reverbel da Silveira, Giada Sebastiani, Leon A. Adams, Wei Chen, Xiaolong Qi, Ivan Ranković, Victor de Lédinghen, Wenjie Lv, Masahide Hamaguchi, Radwan Kassir, Dirk Müller‐Wieland, Manuel Romero‐Gómez, Ying Xu, Yicong Xu, Shiyao Chen, Mohammad Kermansaravi, Mohammad Shafi Kuchay, Sander Lefere, Chetan Parmar, Gregory Y.H. Lip, Chun‐Jen Liu, Fredrik Åberg, George Lau, Jacob George, Shiv Kumar Sarin, Jing-Ya Zhou, Ming‐Hua Zheng, on behalf of the MAFLD ICD-11 coding collaborators, Huai Zhang, Giovanni Targher, Christopher D. Byrne, Seung Up Kim, Vincent Wai-Sun Wong ほか 874 名 - Hepatology International 2024 被引用: 33

  16. COVID-19: Discovery, diagnostics and drug development

    著者: , , , , - Journal of Hepatology 2020 被引用: 453

  17. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kessarin Thanapirom, Mamun Al Mahtab, Undram Lkhagvaa, Oidov Baatarkhuu, Ashok Choudhury, Catherine A. Stedman, Abhijit Chowdhury, A. Kadir Dökmeci, Fu‐Sheng Wang, Han‐Chieh Lin, Jee‐Fu Huang, Jess Howell, Jidong Jia, Mohamed Alboraie, Stuart K. Roberts, Masato Yoneda, Hasmik Ghazinian, Aram Mirijanyan, Yuemin Nan, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Gamal Shiha, Manoj Kumar, Necati Örmecı, Lai Wei, George Lau, Masao Omata, Shiv Kumar Sarin, Jacob George - Hepatology International 2025 被引用: 127

  18. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2008 被引用: 762

  19. Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase†

    著者: , , , , , , , , - Hepatology 2007 被引用: 272

  20. Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2025 被引用: 109

  21. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , - Hepatology 2012 被引用: 205

  22. SO-15 Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 21

  23. Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2004 被引用: 1,141

  24. Silver Nanoparticles Inhibit Hepatitis B virus Replication

    著者: , , , , , , , - Antiviral Therapy 2008 被引用: 600